Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas G. Vogelzang"'
Autor:
Bin Tean Teh, Craig G. Rogers, Arie Belldegrun, Robert Figlin, David Seligson, Robert Amato, Nicholas G. Vogelzang, Walter Stadler, Theresa Nicol, Richard Kahnoski, John Anema, Maria Tretiakova, Michael Pins, Kim Wang, Chunyan Luan, Bin Sing Teh, Puay Hoon Tan, Hiro-omi Kanayama, Masayuki Takahashi, Kyle A. Furge, Kunihiko Futami, Eric J. Kort, Carolina E. Png, Mark W. Betten, Jonathon A. Ditlev, Hyung L. Kim, Min-Han Tan, Ximing J. Yang
Supplementary Figures C1-C2 from A Molecular Classification of Papillary Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755d3e0c0928c447900de6b856bfd0a3
https://doi.org/10.1158/0008-5472.22365210
https://doi.org/10.1158/0008-5472.22365210
Autor:
Bin Tean Teh, Craig G. Rogers, Arie Belldegrun, Robert Figlin, David Seligson, Robert Amato, Nicholas G. Vogelzang, Walter Stadler, Theresa Nicol, Richard Kahnoski, John Anema, Maria Tretiakova, Michael Pins, Kim Wang, Chunyan Luan, Bin Sing Teh, Puay Hoon Tan, Hiro-omi Kanayama, Masayuki Takahashi, Kyle A. Furge, Kunihiko Futami, Eric J. Kort, Carolina E. Png, Mark W. Betten, Jonathon A. Ditlev, Hyung L. Kim, Min-Han Tan, Ximing J. Yang
Supplementary Table 1 from A Molecular Classification of Papillary Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5864b7babe127783d7f3b9cad960482d
https://doi.org/10.1158/0008-5472.22365207
https://doi.org/10.1158/0008-5472.22365207
Autor:
Bin Tean Teh, Craig G. Rogers, Arie Belldegrun, Robert Figlin, David Seligson, Robert Amato, Nicholas G. Vogelzang, Walter Stadler, Theresa Nicol, Richard Kahnoski, John Anema, Maria Tretiakova, Michael Pins, Kim Wang, Chunyan Luan, Bin Sing Teh, Puay Hoon Tan, Hiro-omi Kanayama, Masayuki Takahashi, Kyle A. Furge, Kunihiko Futami, Eric J. Kort, Carolina E. Png, Mark W. Betten, Jonathon A. Ditlev, Hyung L. Kim, Min-Han Tan, Ximing J. Yang
Despite the moderate incidence of papillary renal cell carcinoma (PRCC), there is a disproportionately limited understanding of its underlying genetic programs. There is no effective therapy for metastatic PRCC, and patients are often excluded from k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19db1240b018d748331eb531dbd277ad
https://doi.org/10.1158/0008-5472.c.6494580.v1
https://doi.org/10.1158/0008-5472.c.6494580.v1
Autor:
Min-Han Tan, Michael R. Pins, Maria Tretiakova, Eric J. Kort, Robert A. Figlin, Richard J. Kahnoski, Ximing J. Yang, Chunyan Luan, John Anema, Masayuki Takahashi, Bin Sing Teh, Kim L. Wang, Mark Betten, Arie S. Belldegrun, Puay Hoon Tan, Jonathon A. Ditlev, Theresa L. Nicol, Robert J. Amato, Kyle A. Furge, Hiro-omi Kanayama, Walter M. Stadler, Nicholas G. Vogelzang, Hyung L. Kim, Kunihiko Futami, Craig G. Rogers, David Seligson, Bin Tean Teh, Carolina E. Png
Publikováno v:
Cancer research. 65(13)
Despite the moderate incidence of papillary renal cell carcinoma (PRCC), there is a disproportionately limited understanding of its underlying genetic programs. There is no effective therapy for metastatic PRCC, and patients are often excluded from k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd8f8492c9c05210575f974f3a051221
https://pubmed.ncbi.nlm.nih.gov/15994935
https://pubmed.ncbi.nlm.nih.gov/15994935
